MPLX CEO Michael Hennigan discloses throat cancer diagnosis; says prognosis is curable

MPLX LP

CEO diagnosed with throat cancer, caught early and considered curable per leading medical institutions.
Will undergo seven-week radiation and chemotherapy treatment while continuing as CEO with limited travel.
Board fully apprised and supportive; no leadership change announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.